https://scholarlycommons.henryford.com/hematologyoncology_articles/268/
"Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC " by Nicolas Girard, Anna...
INTRODUCTION: The activity of immune checkpoint inhibitors (ICIs) in NSCLC harboring EGFR exon 20 insertion mutations (ex20ins) has not been closely examined...